| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telemedicine | 15 | 2025 | 186 | 7.220 |
Why?
|
| Emergency Service, Hospital | 46 | 2025 | 368 | 6.060 |
Why?
|
| Electronic Health Records | 20 | 2025 | 697 | 4.020 |
Why?
|
| Humans | 110 | 2025 | 17762 | 2.730 |
Why?
|
| Patient Acceptance of Health Care | 10 | 2024 | 390 | 2.680 |
Why?
|
| Male | 80 | 2025 | 10106 | 2.540 |
Why?
|
| Pulmonary Embolism | 12 | 2023 | 44 | 2.450 |
Why?
|
| Primary Health Care | 11 | 2024 | 769 | 2.450 |
Why?
|
| Female | 83 | 2025 | 12740 | 2.360 |
Why?
|
| Office Visits | 6 | 2024 | 80 | 2.290 |
Why?
|
| Health Expenditures | 5 | 2024 | 75 | 2.260 |
Why?
|
| Adult | 58 | 2025 | 7678 | 2.250 |
Why?
|
| Middle Aged | 60 | 2025 | 7988 | 2.150 |
Why?
|
| Patient Portals | 4 | 2020 | 24 | 2.040 |
Why?
|
| Diabetes Mellitus | 6 | 2020 | 487 | 2.030 |
Why?
|
| Aged | 51 | 2025 | 6150 | 2.030 |
Why?
|
| Retrospective Studies | 35 | 2025 | 2461 | 2.000 |
Why?
|
| Anticoagulants | 8 | 2024 | 127 | 2.000 |
Why?
|
| Decision Support Systems, Clinical | 8 | 2024 | 53 | 1.960 |
Why?
|
| Delivery of Health Care, Integrated | 12 | 2021 | 535 | 1.900 |
Why?
|
| Electronic Mail | 5 | 2021 | 51 | 1.700 |
Why?
|
| Cost Sharing | 7 | 2024 | 30 | 1.670 |
Why?
|
| Videoconferencing | 4 | 2021 | 7 | 1.620 |
Why?
|
| Medication Adherence | 3 | 2020 | 245 | 1.470 |
Why?
|
| Pandemics | 7 | 2024 | 287 | 1.460 |
Why?
|
| California | 29 | 2025 | 2326 | 1.450 |
Why?
|
| Patient Satisfaction | 5 | 2019 | 212 | 1.450 |
Why?
|
| Ambulatory Care | 5 | 2022 | 247 | 1.450 |
Why?
|
| Atrial Fibrillation | 6 | 2024 | 170 | 1.410 |
Why?
|
| Deductibles and Coinsurance | 5 | 2017 | 30 | 1.370 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2025 | 5 | 1.320 |
Why?
|
| Chronic Disease | 4 | 2019 | 428 | 1.290 |
Why?
|
| Telephone | 7 | 2024 | 161 | 1.290 |
Why?
|
| Triage | 3 | 2025 | 16 | 1.270 |
Why?
|
| Internet | 4 | 2020 | 231 | 1.210 |
Why?
|
| Young Adult | 20 | 2024 | 2461 | 1.190 |
Why?
|
| Adolescent | 23 | 2024 | 3685 | 1.170 |
Why?
|
| Language | 2 | 2025 | 53 | 1.150 |
Why?
|
| Physicians | 4 | 2023 | 137 | 1.130 |
Why?
|
| Health Services Accessibility | 7 | 2025 | 292 | 1.110 |
Why?
|
| Insurance, Health | 5 | 2017 | 183 | 1.110 |
Why?
|
| Health Benefit Plans, Employee | 5 | 2017 | 20 | 1.100 |
Why?
|
| Choice Behavior | 2 | 2020 | 46 | 1.090 |
Why?
|
| Heart Failure | 3 | 2023 | 396 | 1.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2014 | 382 | 1.080 |
Why?
|
| Risk Assessment | 10 | 2025 | 1101 | 1.040 |
Why?
|
| Physicians, Primary Care | 3 | 2021 | 72 | 1.010 |
Why?
|
| Consumer Behavior | 2 | 2020 | 29 | 1.010 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2025 | 6 | 0.980 |
Why?
|
| Cross-Sectional Studies | 13 | 2024 | 1330 | 0.980 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 19 | 0.960 |
Why?
|
| Patient Protection and Affordable Care Act | 2 | 2024 | 42 | 0.960 |
Why?
|
| Pregnancy Rate | 1 | 2024 | 6 | 0.960 |
Why?
|
| Contraception | 1 | 2024 | 25 | 0.940 |
Why?
|
| Abortion, Induced | 1 | 2024 | 18 | 0.940 |
Why?
|
| Craniocerebral Trauma | 5 | 2021 | 10 | 0.930 |
Why?
|
| Hospitalization | 9 | 2024 | 808 | 0.910 |
Why?
|
| Postoperative Complications | 1 | 2025 | 102 | 0.910 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2023 | 210 | 0.900 |
Why?
|
| United States | 18 | 2025 | 4003 | 0.890 |
Why?
|
| Aged, 80 and over | 19 | 2025 | 1923 | 0.880 |
Why?
|
| Musculoskeletal Pain | 1 | 2023 | 27 | 0.860 |
Why?
|
| Financing, Personal | 3 | 2017 | 20 | 0.840 |
Why?
|
| Glycated Hemoglobin A | 3 | 2020 | 216 | 0.840 |
Why?
|
| Specialties, Surgical | 1 | 2022 | 2 | 0.810 |
Why?
|
| Hypoglycemic Agents | 2 | 2017 | 271 | 0.810 |
Why?
|
| Allied Health Personnel | 1 | 2022 | 11 | 0.800 |
Why?
|
| Healthcare Disparities | 2 | 2021 | 203 | 0.790 |
Why?
|
| Delivery of Health Care | 2 | 2022 | 415 | 0.780 |
Why?
|
| Aftercare | 1 | 2021 | 49 | 0.750 |
Why?
|
| Contrast Media | 1 | 2021 | 9 | 0.740 |
Why?
|
| Warfarin | 4 | 2018 | 74 | 0.740 |
Why?
|
| Multitasking Behavior | 1 | 2021 | 2 | 0.730 |
Why?
|
| Attention | 1 | 2021 | 10 | 0.730 |
Why?
|
| Attitude of Health Personnel | 7 | 2021 | 213 | 0.710 |
Why?
|
| Communication | 3 | 2018 | 194 | 0.710 |
Why?
|
| Machine Learning | 1 | 2020 | 46 | 0.700 |
Why?
|
| Caregivers | 2 | 2019 | 129 | 0.690 |
Why?
|
| Insurance Coverage | 6 | 2020 | 106 | 0.690 |
Why?
|
| Stroke | 6 | 2024 | 315 | 0.680 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 246 | 0.650 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 172 | 0.650 |
Why?
|
| Income | 5 | 2016 | 90 | 0.650 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2021 | 179 | 0.640 |
Why?
|
| Atrial Flutter | 4 | 2023 | 15 | 0.630 |
Why?
|
| Ticlopidine | 3 | 2013 | 16 | 0.620 |
Why?
|
| Cohort Studies | 10 | 2024 | 2586 | 0.620 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2013 | 24 | 0.620 |
Why?
|
| Chest Pain | 3 | 2024 | 14 | 0.580 |
Why?
|
| Patient Discharge | 4 | 2024 | 154 | 0.580 |
Why?
|
| Health Maintenance Organizations | 5 | 2013 | 417 | 0.570 |
Why?
|
| Intracranial Hemorrhages | 3 | 2013 | 16 | 0.540 |
Why?
|
| Computer Security | 1 | 2016 | 5 | 0.540 |
Why?
|
| Access to Information | 1 | 2016 | 13 | 0.530 |
Why?
|
| Efficiency, Organizational | 2 | 2015 | 32 | 0.530 |
Why?
|
| Diffusion of Innovation | 1 | 2016 | 42 | 0.530 |
Why?
|
| Motivation | 1 | 2017 | 131 | 0.520 |
Why?
|
| Quality of Health Care | 2 | 2015 | 326 | 0.520 |
Why?
|
| Asthma | 1 | 2019 | 385 | 0.520 |
Why?
|
| Insurance, Pharmaceutical Services | 2 | 2008 | 25 | 0.510 |
Why?
|
| Surveys and Questionnaires | 10 | 2021 | 1321 | 0.500 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 197 | 0.500 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 331 | 0.490 |
Why?
|
| Patient Participation | 1 | 2016 | 134 | 0.490 |
Why?
|
| Continental Population Groups | 2 | 2016 | 302 | 0.470 |
Why?
|
| Child | 10 | 2024 | 2491 | 0.470 |
Why?
|
| Catheterization, Central Venous | 4 | 2014 | 12 | 0.460 |
Why?
|
| Health Care Costs | 2 | 2012 | 229 | 0.440 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2019 | 755 | 0.430 |
Why?
|
| Infant | 5 | 2024 | 1192 | 0.430 |
Why?
|
| Ambulatory Care Facilities | 3 | 2020 | 69 | 0.430 |
Why?
|
| Health Planning | 1 | 2012 | 16 | 0.420 |
Why?
|
| Community Participation | 1 | 2012 | 30 | 0.410 |
Why?
|
| Medical Savings Accounts | 1 | 2012 | 1 | 0.410 |
Why?
|
| Severity of Illness Index | 5 | 2024 | 455 | 0.410 |
Why?
|
| Follow-Up Studies | 5 | 2023 | 1213 | 0.410 |
Why?
|
| Child, Preschool | 5 | 2024 | 1419 | 0.410 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 2012 | 228 | 0.390 |
Why?
|
| Patient Compliance | 2 | 2018 | 300 | 0.380 |
Why?
|
| Age Factors | 6 | 2020 | 918 | 0.370 |
Why?
|
| Preventive Health Services | 1 | 2012 | 160 | 0.370 |
Why?
|
| Qualitative Research | 4 | 2022 | 256 | 0.360 |
Why?
|
| Medical Oncology | 2 | 2021 | 32 | 0.360 |
Why?
|
| Appendicitis | 2 | 2020 | 15 | 0.340 |
Why?
|
| Interviews as Topic | 5 | 2013 | 305 | 0.330 |
Why?
|
| Physician-Patient Relations | 3 | 2019 | 188 | 0.330 |
Why?
|
| Multivariate Analysis | 6 | 2018 | 568 | 0.320 |
Why?
|
| Sepsis | 3 | 2014 | 70 | 0.320 |
Why?
|
| Predictive Value of Tests | 4 | 2024 | 354 | 0.320 |
Why?
|
| Drug Costs | 2 | 2013 | 34 | 0.310 |
Why?
|
| Patient Care Team | 3 | 2021 | 113 | 0.310 |
Why?
|
| Managed Care Programs | 1 | 2009 | 325 | 0.280 |
Why?
|
| Cluster Analysis | 3 | 2024 | 90 | 0.280 |
Why?
|
| Medicare | 4 | 2022 | 205 | 0.270 |
Why?
|
| Disease Management | 2 | 2019 | 135 | 0.270 |
Why?
|
| Acute Disease | 3 | 2022 | 142 | 0.260 |
Why?
|
| Length of Stay | 2 | 2018 | 181 | 0.260 |
Why?
|
| Medical Order Entry Systems | 2 | 2016 | 14 | 0.260 |
Why?
|
| Neoplasms | 2 | 2021 | 444 | 0.260 |
Why?
|
| Outpatients | 2 | 2019 | 110 | 0.260 |
Why?
|
| Fibrinolytic Agents | 2 | 2016 | 44 | 0.250 |
Why?
|
| Personal Health Services | 1 | 2005 | 3 | 0.250 |
Why?
|
| Referral and Consultation | 2 | 2024 | 169 | 0.250 |
Why?
|
| Emergencies | 1 | 2025 | 6 | 0.240 |
Why?
|
| Ritonavir | 1 | 2025 | 10 | 0.240 |
Why?
|
| Surgical Procedures, Operative | 1 | 2025 | 16 | 0.240 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2024 | 1 | 0.240 |
Why?
|
| Population Surveillance | 4 | 2015 | 264 | 0.240 |
Why?
|
| Geriatric Assessment | 1 | 2025 | 39 | 0.240 |
Why?
|
| Contraception Behavior | 1 | 2024 | 16 | 0.240 |
Why?
|
| Gonorrhea | 2 | 2015 | 18 | 0.240 |
Why?
|
| Health Equity | 1 | 2025 | 22 | 0.240 |
Why?
|
| Pharmacists | 1 | 2025 | 50 | 0.240 |
Why?
|
| Pediatrics | 2 | 2024 | 160 | 0.230 |
Why?
|
| Health Care Surveys | 5 | 2014 | 230 | 0.230 |
Why?
|
| Meningitis, Bacterial | 1 | 2024 | 1 | 0.230 |
Why?
|
| Intracranial Aneurysm | 1 | 2024 | 4 | 0.230 |
Why?
|
| Patient Selection | 3 | 2020 | 190 | 0.220 |
Why?
|
| Emergency Treatment | 2 | 2014 | 7 | 0.220 |
Why?
|
| Cholesterol, LDL | 2 | 2015 | 119 | 0.220 |
Why?
|
| Hydronephrosis | 1 | 2023 | 2 | 0.210 |
Why?
|
| Ureteral Calculi | 1 | 2023 | 2 | 0.210 |
Why?
|
| Prescription Fees | 1 | 2003 | 4 | 0.210 |
Why?
|
| Organizations | 1 | 2022 | 10 | 0.200 |
Why?
|
| Leadership | 1 | 2022 | 39 | 0.200 |
Why?
|
| Back Pain | 1 | 2022 | 33 | 0.200 |
Why?
|
| Head Injuries, Closed | 1 | 2021 | 1 | 0.200 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2021 | 4 | 0.200 |
Why?
|
| Time Factors | 8 | 2024 | 1093 | 0.190 |
Why?
|
| Appointments and Schedules | 1 | 2021 | 26 | 0.190 |
Why?
|
| Administration, Intravenous | 1 | 2021 | 6 | 0.190 |
Why?
|
| Workload | 1 | 2021 | 30 | 0.180 |
Why?
|
| Incidence | 3 | 2021 | 1266 | 0.180 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2021 | 85 | 0.180 |
Why?
|
| Propensity Score | 1 | 2021 | 85 | 0.180 |
Why?
|
| Socioeconomic Factors | 4 | 2017 | 630 | 0.180 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 44 | 0.180 |
Why?
|
| Electric Countershock | 2 | 2017 | 16 | 0.180 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2017 | 12 | 0.180 |
Why?
|
| Shock, Cardiogenic | 1 | 2020 | 6 | 0.180 |
Why?
|
| Transportation | 1 | 2020 | 12 | 0.180 |
Why?
|
| Heart Arrest | 1 | 2020 | 34 | 0.170 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 18 | 0.170 |
Why?
|
| Syncope | 1 | 2020 | 12 | 0.170 |
Why?
|
| Risk Factors | 8 | 2024 | 3356 | 0.170 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1120 | 0.170 |
Why?
|
| Occupational Stress | 1 | 2019 | 3 | 0.170 |
Why?
|
| Self-Management | 1 | 2020 | 29 | 0.170 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 9 | 0.160 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 48 | 0.160 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2019 | 20 | 0.160 |
Why?
|
| Text Messaging | 1 | 2019 | 29 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 49 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 56 | 0.160 |
Why?
|
| Pregnancy | 1 | 2024 | 1524 | 0.160 |
Why?
|
| After-Hours Care | 1 | 2018 | 2 | 0.160 |
Why?
|
| Prospective Studies | 6 | 2020 | 1279 | 0.160 |
Why?
|
| Cancer Survivors | 1 | 2020 | 85 | 0.160 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2015 | 2 | 0.150 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 238 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2017 | 14 | 0.150 |
Why?
|
| Electrocardiography | 3 | 2024 | 42 | 0.140 |
Why?
|
| Prognosis | 4 | 2024 | 609 | 0.140 |
Why?
|
| Health Status | 3 | 2015 | 298 | 0.140 |
Why?
|
| Australia | 1 | 2017 | 22 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2018 | 53 | 0.140 |
Why?
|
| Comorbidity | 2 | 2017 | 597 | 0.140 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 105 | 0.140 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 39 | 0.140 |
Why?
|
| Logistic Models | 6 | 2019 | 927 | 0.140 |
Why?
|
| Guideline Adherence | 2 | 2015 | 157 | 0.130 |
Why?
|
| Demography | 1 | 2016 | 101 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2015 | 80 | 0.130 |
Why?
|
| Patient Preference | 1 | 2016 | 48 | 0.130 |
Why?
|
| Models, Economic | 1 | 2015 | 19 | 0.130 |
Why?
|
| Abdominal Pain | 3 | 2020 | 15 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 172 | 0.130 |
Why?
|
| Quality of Life | 2 | 2018 | 510 | 0.130 |
Why?
|
| Prescription Drugs | 1 | 2015 | 31 | 0.130 |
Why?
|
| Poverty | 2 | 2014 | 167 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 719 | 0.120 |
Why?
|
| Ceftriaxone | 1 | 2015 | 2 | 0.120 |
Why?
|
| Health Information Exchange | 1 | 2014 | 3 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2014 | 2 | 0.120 |
Why?
|
| Thorax | 1 | 2014 | 5 | 0.120 |
Why?
|
| Censuses | 1 | 2014 | 31 | 0.120 |
Why?
|
| Hypertension | 1 | 2019 | 504 | 0.120 |
Why?
|
| Housing | 1 | 2014 | 39 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 513 | 0.120 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 3 | 0.120 |
Why?
|
| Quality Improvement | 2 | 2015 | 194 | 0.120 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 15 | 0.110 |
Why?
|
| Hemorrhage | 1 | 2014 | 62 | 0.110 |
Why?
|
| Patient Care | 1 | 2013 | 35 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2014 | 99 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 615 | 0.110 |
Why?
|
| Medicare Part D | 1 | 2013 | 15 | 0.110 |
Why?
|
| Intracranial Hemorrhage, Traumatic | 1 | 2013 | 1 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 141 | 0.110 |
Why?
|
| Troponin | 2 | 2024 | 9 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2012 | 21 | 0.100 |
Why?
|
| Myocardial Revascularization | 2 | 2024 | 12 | 0.100 |
Why?
|
| Hypolipidemic Agents | 1 | 2012 | 40 | 0.100 |
Why?
|
| American Recovery and Reinvestment Act | 1 | 2012 | 1 | 0.100 |
Why?
|
| Consumer Health Information | 1 | 2012 | 14 | 0.100 |
Why?
|
| Disease Outbreaks | 1 | 2012 | 36 | 0.100 |
Why?
|
| Certification | 1 | 2011 | 3 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2012 | 300 | 0.100 |
Why?
|
| Gastroenteritis | 1 | 2012 | 26 | 0.100 |
Why?
|
| Primary Prevention | 1 | 2012 | 73 | 0.100 |
Why?
|
| Cause of Death | 1 | 2012 | 181 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2023 | 1260 | 0.090 |
Why?
|
| Registries | 1 | 2013 | 472 | 0.090 |
Why?
|
| Sex Factors | 3 | 2021 | 644 | 0.090 |
Why?
|
| Models, Organizational | 1 | 2010 | 55 | 0.090 |
Why?
|
| Medically Uninsured | 1 | 2010 | 44 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2010 | 64 | 0.080 |
Why?
|
| Patient Care Management | 1 | 2009 | 30 | 0.080 |
Why?
|
| Decision Making | 2 | 2008 | 183 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 304 | 0.080 |
Why?
|
| ROC Curve | 2 | 2020 | 77 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2008 | 5 | 0.080 |
Why?
|
| Glasgow Coma Scale | 2 | 2021 | 3 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2008 | 128 | 0.070 |
Why?
|
| Decision Support Techniques | 2 | 2019 | 88 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 599 | 0.070 |
Why?
|
| Algorithms | 2 | 2023 | 239 | 0.070 |
Why?
|
| Prevalence | 2 | 2023 | 886 | 0.070 |
Why?
|
| Educational Status | 3 | 2014 | 200 | 0.070 |
Why?
|
| Trust | 1 | 2025 | 31 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2025 | 21 | 0.060 |
Why?
|
| Computed Tomography Angiography | 1 | 2024 | 4 | 0.060 |
Why?
|
| Clinical Protocols | 2 | 2015 | 43 | 0.060 |
Why?
|
| Headache | 1 | 2024 | 14 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 2 | 0.060 |
Why?
|
| Clinical Decision-Making | 1 | 2023 | 34 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 34 | 0.050 |
Why?
|
| Survival Rate | 2 | 2015 | 260 | 0.050 |
Why?
|
| Biomarkers | 1 | 2024 | 303 | 0.050 |
Why?
|
| Fever | 1 | 2023 | 55 | 0.050 |
Why?
|
| Heart Rate | 1 | 2023 | 41 | 0.050 |
Why?
|
| Drugs, Generic | 1 | 2003 | 4 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2023 | 61 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 60 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2015 | 145 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2024 | 855 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 151 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 328 | 0.050 |
Why?
|
| Troponin I | 1 | 2020 | 8 | 0.040 |
Why?
|
| House Calls | 1 | 2020 | 11 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 35 | 0.040 |
Why?
|
| Software | 1 | 2019 | 22 | 0.040 |
Why?
|
| Proxy | 1 | 2019 | 4 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 46 | 0.040 |
Why?
|
| Nausea | 1 | 2019 | 8 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 21 | 0.040 |
Why?
|
| Vomiting | 1 | 2019 | 13 | 0.040 |
Why?
|
| Mortality | 1 | 2020 | 118 | 0.040 |
Why?
|
| Confidentiality | 1 | 2019 | 27 | 0.040 |
Why?
|
| Adnexal Diseases | 1 | 1999 | 1 | 0.040 |
Why?
|
| Cysts | 1 | 1999 | 1 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1999 | 1 | 0.040 |
Why?
|
| Proteins | 1 | 1999 | 16 | 0.040 |
Why?
|
| Glucose | 1 | 1999 | 30 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2020 | 105 | 0.040 |
Why?
|
| Migraine Disorders | 1 | 2019 | 17 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 132 | 0.040 |
Why?
|
| Medicaid | 1 | 2020 | 190 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 20 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 145 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2015 | 7 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 23 | 0.030 |
Why?
|
| Cross Infection | 1 | 2015 | 27 | 0.030 |
Why?
|
| Automation | 1 | 2015 | 24 | 0.030 |
Why?
|
| Doxycycline | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cephalosporin Resistance | 1 | 2015 | 1 | 0.030 |
Why?
|
| Azithromycin | 1 | 2015 | 3 | 0.030 |
Why?
|
| Documentation | 1 | 2015 | 42 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2015 | 8 | 0.030 |
Why?
|
| Meaningful Use | 1 | 2014 | 5 | 0.030 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 12 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2015 | 37 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2014 | 23 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 114 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 4 | 0.030 |
Why?
|
| Inservice Training | 1 | 2014 | 14 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2014 | 45 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2014 | 53 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 91 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 37 | 0.030 |
Why?
|
| Radiography | 1 | 2013 | 39 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2012 | 2 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2012 | 4 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2012 | 12 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2015 | 164 | 0.030 |
Why?
|
| Physical Examination | 1 | 2012 | 20 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2013 | 223 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 30 | 0.030 |
Why?
|
| Community Health Workers | 1 | 2012 | 13 | 0.030 |
Why?
|
| Self Report | 1 | 2014 | 253 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2012 | 72 | 0.030 |
Why?
|
| Cryptosporidium | 1 | 2012 | 1 | 0.030 |
Why?
|
| Serotyping | 1 | 2012 | 3 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 1 | 2012 | 4 | 0.030 |
Why?
|
| Economic Recession | 1 | 2012 | 4 | 0.030 |
Why?
|
| Salmonella | 1 | 2012 | 2 | 0.030 |
Why?
|
| Antidiarrheals | 1 | 2012 | 2 | 0.030 |
Why?
|
| Foodborne Diseases | 1 | 2012 | 5 | 0.030 |
Why?
|
| Unemployment | 1 | 2012 | 12 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2014 | 250 | 0.020 |
Why?
|
| Comprehensive Health Care | 1 | 2012 | 7 | 0.020 |
Why?
|
| Financing, Government | 1 | 2012 | 28 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 237 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2011 | 27 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 80 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 517 | 0.020 |
Why?
|
| Medical Staff | 1 | 2010 | 1 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 18 | 0.020 |
Why?
|
| Professional Role | 1 | 2010 | 10 | 0.020 |
Why?
|
| Physicians, Family | 1 | 2010 | 44 | 0.020 |
Why?
|
| New York City | 1 | 2010 | 21 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 16 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2009 | 20 | 0.020 |
Why?
|
| Family Practice | 1 | 2009 | 44 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 381 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2004 | 671 | 0.010 |
Why?
|
| Health Behavior | 1 | 2004 | 360 | 0.010 |
Why?
|
| Cyst Fluid | 1 | 1999 | 2 | 0.010 |
Why?
|